VIROMARKERS at ICAR 2026: Abstracts Published in STI special issue
VIROMARKERS contributions presented at ICAR 2026 are now formally published in Sexually Transmitted Infections (BMJ Group)🔬 The ICAR 2026 Abstracts issue brings these results into the peer-reviewed literature, making them fully citable and accessible to the wider research community 🧬 Check the publication below:📖 Sexually Transmitted Infections (STI), Volume 102, Supplement 1 (June 2026) 🔗 BMJ STI ICAR […]
VIROMARKERS presenting at the ISMD 2026
Our scientific dissemination activities continue! At the International Symposium on Molecular Diagnostics (ISMD2026), Lorenzo Piermatteo (UTOV) presented the latest findings from its ongoing work on HDV RNA quantification in VIROMARKERS 🧬 Oral presentation: Relevance of the Highly Sensitive Assays for HDV-RNA QuantificationLorenzo Piermatteo (UTOV) Discover the event here: http://www.ismd2026.oeglmkc.at/index_e.html
VIROMARKERS at the EMHH 2026
The VIROMARKERS consortium took part in the 24th European Meeting on HIV & Hepatitis (EMHH 2026), where project partners contributed with oral presentations, posters and invited lectures presenting recent results and ongoing work. The conference was a useful opportunity to exchange ideas, discuss current research questions and explore new directions in the field.It also allowed […]
VIROMARKERS at EASL 2026 Highlights
We are glad to have brought the VIROMARKERS project to the European Association for the Study of the Liver Congress (EASL 2026), held in Barcelona, Spain from 27 to 30 May 2026. The congress was a valuable opportunity to present our recent research and engage with the scientific community working in liver disease.It also provided […]
VIROMARKERS presentations at ICAR 2026
The VIROMARKERS team proudly brought the project to the Italian Conference on AIDS and Antiviral Research (ICAR 2026), held in Catania, Italy from 20 to 22 May 2026. Here the conference website: https://www.icar2026.com/index.php A great opportunity to present the project, share and discuss innovation and connect with the scientific community working on HIV and […]
2026 – Chronic HDV Infection Shows Higher HBsAg Isoform Levels than HBVInfection, Paralleling HDV Replicative Activity
Stefano D’Anna, Lorenzo Piermatteo, Antonella Olivero, Leonardo Duca, Alessia Magnapera, Ilaria Grossi, Caterina Tramontozzi, Giulia Torre, Elisabetta Teti, Andrea Di Lorenzo, Vincenzo Malagnino, Marco Iannetta, Sandro Grelli, Pierpaolo Paba, Ada Bertoli, Francesca Ceccherini-Silberstein, Leonardo Baiocchi, Simona Francioso, Ilaria Lenci, Annalisa Saracino, Alessia Ciancio, Giuseppina Brancaccio, Loredana Sarmati, Mario Rizzetto, Gian Paolo Caviglia, Romina Salpini […]
AREVIR 2026 – Joint EuCARE/VIROMARKERS Session
On 24–25 April, we gathered in Cologne, Germany for AREVIR 2026! The programme featured a dedicated EuCARE/VIROMARKERS session on 24 April, bringing together project partners for presentations and in-depth discussion within the broader meeting framework. These moments are key to keeping the consortium aligned beyond formal reporting lines, allowing perspectives to converge and ongoing […]
IHI Coordinator Training Day
Today EuResist Network GEIE took part in the Innovative Health Initiative (IHI) Coordinator Training Day in Brussels. The session offered a great opportunity to exchange on financial and administrative management, reporting practices and common challenges across IHI projects. A useful moment to align, learn and bring back practical insights to support the ongoing work of VIROMARKERS!
World Health Day: IHI features VIROMARKERS – Together for Health, Stand with Science
On the occasion of World Health Day, the Innovative Health Initiative (IHI) has highlighted the work of VIROMARKERS as part of its “Together for Health, Stand with Science” message. The piece also includes the perspective of Francesca Incardona (EuResist Network), Project Coordinator of VIROMARKERS, reflecting the value of public-private partnership in fostering collaboration and impactful […]
VIROMARKERS at CROI 2026
From 22 to 25 February 2026, members of the VIROMARKERS consortium, including University of Rome Tor Vergata, ASST Santi Paolo e Carlo, University of Cologne and MIB GmbH, attended the Conference on Retroviruses and Opportunistic Infections 2026 in Denver. During the conference, a VIROMARKERS-related study was presented in the lecture “Characterization of mutations outside the […]